IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
40.53%
1 Year Est. Return
+40.53%
AUM
$903M
AUM Growth
-$228M
(-20%)
Holding
109
Top Buys
| 1 | +$28.3M | |
| 2 | +$27.9M | |
| 3 | +$22.6M | |
| 4 |
Baxter International
BAX
|
+$17.1M |
| 5 |
Ascendis Pharma
ASND
|
+$15.6M |
Top Sells
| 1 | +$30.3M | |
| 2 | +$29.6M | |
| 3 | +$29.3M | |
| 4 |
Intuitive Surgical
ISRG
|
+$20.9M |
| 5 |
CVS Health
CVS
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Kyverna Therapeutics
KYTX
$322M
| – | – |
-350,000
|
|
||
|
NARI
102
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-350,000
|
|
||
103
Humana
HUM
$35B
| – | – |
-40,000
|
|
||
104
Illumina
ILMN
$15.4B
| – | – |
-40,000
|
|
||
|
105
Intuitive Surgical
ISRG
$194B
| – | – |
-40,000
|
|
||
106
Janux Therapeutics
JANX
$1.5B
| – | – |
-200,000
|
|
||
107
Keros Therapeutics
KROS
$458M
| – | – |
-450,000
|
|
||
108
Eli Lilly
LLY
$740B
| – | – |
-38,000
|
|
||
109
Merck
MRK
$219B
| – | – |
-200,000
|
|